24 Jan 2025 | Events
We are delighted to share that Technophage’s Clinical Trial Director, Margarida Barreto, participated in the REVERSE 2 / TP-102_102 Investigator Meeting on 19th January 2025 in Hyderabad, India. The event was promoted and organized by our colleagues at VectorB2B...
27 Nov 2024 | Events
This year, we combined our traditional annual team-building with a festive Christmas celebration, bringing together all our collaborators for a memorable day. The event kicked off with insightful talks from our directors, who shared a summary of 2024, highlighted key...
28 Fev 2024 | Events
Our Chief Scientific Officer and Deputy CEO, Sofia Corte-Real, will act as both the chair and a speaker at the upcoming 6th Annual Bacteriophage Summit scheduled for February 27 to 29 in Boston! Sofia’s presentation will focus on the ongoing Phase 2b Clinical...
15 Mar 2023 | Events
Technophage’s Head of Neurosciences Raquel Ferreira is currently in London at the 13th Annual World ADC 2023, learning with the best, about the latest products, projects and technologies on the field. If you are interested in ADCs you can still join us and have...
18 Out 2021 | Events
Last week TechnoPhage held its Annual Meeting where the CEO, Miguel Garcia, took the opportunity to speak to the collaborators about recent achievements and future perspectives and goals. It was a great opportunity for the whole team to be reunited for the first time...
23 Mar 2021 | Events
Technophage will be presenting the first information on the recently initiated TP-102 clinical study at the Bacteriophage Therapy Summit 2021 – Digital Event tomorrow, March 24, at 2:45pm EDT. The talk entitled Going into REVERSE: Assessing the Safety of...
